Metabolomics of Aspergillus fumigatus

Jens C Frisvad1, Christian Rank, Kristian F Nielsen

  • 1Center for Microbial Biotechnology, DTU Biosys, Technical University of Denmark, Kgs. Lyngby, Denmark. jcf@bio.dtu.dk

Medical Mycology
|September 3, 2008
PubMed

Insights

Aspergillus fumigatus produces numerous bioactive secondary metabolites, including fumigatins and gliotoxins. Researchers identified 12 families of these extrolites using advanced detection methods.

Area of Science:

  • Mycology
  • Biochemistry
  • Medical Microbiology

Background:

  • Aspergillus fumigatus is a significant fungal pathogen causing lung infections.
  • This fungus produces a wide array of extrolites, including secondary metabolites, acids, and proteins.
  • Over 226 potentially bioactive secondary metabolites have been identified in A. fumigatus, categorized into 24 biosynthetic families.

Purpose of the Study:

  • To identify and characterize the secondary metabolites produced by Aspergillus fumigatus.
  • To investigate the presence of specific extrolite families within A. fumigatus isolates.
  • To compare extrolite profiles between A. fumigatus and related species like Aspergillus lentulus.

Main Methods:

  • High-performance liquid chromatography (HPLC) with diode array detection.
  • Mass spectrometry (MS) for metabolite identification.
  • Analysis of extrolite profiles from A. fumigatus and A. lentulus isolates.

Main Results:

  • Representatives from 12 secondary metabolite families were detected in A. fumigatus.
  • Detected families include fumigatins, fumigaclavines, fumiquinazolines, gliotoxins, and others.
  • Sphingofungins were tentatively detected in A. fumigatus and A. lentulus, potentially similar to fumonisins.

Conclusions:

  • Aspergillus fumigatus produces a diverse range of secondary metabolites, confirming the presence of 12 known biosynthetic families.
  • The study provides evidence for the production of fumiquinazolines by all isolates, with potential detection of sphingofungins.
  • Further research is needed to clarify the role and production of certain metabolites like sphingofungins and to confirm previously reported but potentially misidentified mycotoxins.